Login / Signup

PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis.

Min XiongZhenghe ChenChao ZhouXiaochun YangWanming HuYongluo JiangRongliang ZhengWei FanYonggao MouXiaoping Lin
Published in: Recent patents on anti-cancer drug discovery (2024)
This primitive study shows multiparameter PSMA PET/MR to be useful in identifying glioma (especially GBM) recurrence by providing excellent tumor background comparison, tumor heterogeneity, recurrence prediction and prognosis information, although it did not improve the diagnostic performance compared to conventional MRI. Further and larger studies are required to define its potential clinical application in this setting.
Keyphrases